R.L. Poorter

Complications of an implantable venous access device (Port-a-Cath®) during intermittent continuous infusion of chemotherapy

R.L. Poorter, Fanny N. Lauw, Willem A. Bemelman et al. · European Journal of Cancer · 1996 · 125 citations

Assisted Circulation, Venous Disease, Patient Safety +4

Radiotherapy of squamous cell carcinoma of the nasal vestibule

Johannes A. Langendijk, R.L. Poorter, C. René Leemans et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 57 citations · Full text

Radiation Therapy, Squamous Cell Carcinoma, Medicine +4

Toxicity of two cisplatin‐based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer

Dirk Rades, Fabian Fehlauer, Mashid Sheikh‐Sarraf et al. · Head & Neck · 2007 · 39 citations · Full text

Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: Relationship between plasma concentrations and clinical parameters

R.L. Poorter, Godefridus J. Peters, Piet Bakker et al. · European Journal of Cancer · 1995 · 18 citations

Plasma Concentrations, Oncology, Gastrointestinal Oncology +9

No Circadian Variation of Dihydropyrimidine Dehydrogenase, Uridine Phosphorylase, β-Alanine, and 5-Fluorouracil During Continuous Infusion of 5-Fluorouracil

André B. P. Kuilenburg, R.L. Poorter, Godefridus J. Peters et al. · Advances in experimental medicine and biology · 1998 · 12 citations

Biochemistry, Circadian Variation, Medicine +7